The International Trade Commission agrees it's FDA's job to regulate the dietary supplement industry as it rejects Amarin Corp. PLC's fair trade complaint alleging some omega-3 ingredients are unapproved new drugs.
The attempt by Amarin to eliminate competition for its Rx drug Vascepa from some omega-3 dietary supplements likely now won't...






